186 related articles for article (PubMed ID: 38794642)
1. Effect of Vitamin D3 Supplementation on Severe COVID-19: A Meta-Analysis of Randomized Clinical Trials.
Sobczak M; Pawliczak R
Nutrients; 2024 May; 16(10):. PubMed ID: 38794642
[TBL] [Abstract][Full Text] [Related]
2. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.
Murai IH; Fernandes AL; Sales LP; Pinto AJ; Goessler KF; Duran CSC; Silva CBR; Franco AS; Macedo MB; Dalmolin HHH; Baggio J; Balbi GGM; Reis BZ; Antonangelo L; Caparbo VF; Gualano B; Pereira RMR
JAMA; 2021 Mar; 325(11):1053-1060. PubMed ID: 33595634
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic high-dose vitamin D for vitamin D-deficient severe COVID-19 disease: randomized, double-blind, placebo-controlled study (SHADE-S).
Singh A; Rastogi A; Puri GD; Ganesh V; Naik NB; Kajal K; Kahlon S; Soni SL; Kaloria N; Saini K; Hazarika A; Mahajan V; Singla K; Bhadada S; Soni V
J Public Health (Oxf); 2024 May; 46(2):256-266. PubMed ID: 38291897
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
[TBL] [Abstract][Full Text] [Related]
5. Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial.
Sabico S; Enani MA; Sheshah E; Aljohani NJ; Aldisi DA; Alotaibi NH; Alshingetti N; Alomar SY; Alnaami AM; Amer OE; Hussain SD; Al-Daghri NM
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202578
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Vitamin D Supplementation on the Length of Hospitalisation, Intensive Care Unit Admission, and Mortality in COVID-19-A Systematic Review and Meta-Analysis.
Sîrbu AC; Sabin O; Bocșan IC; Vesa ȘC; Buzoianu AD
Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571407
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D supplementation for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.
Kümmel LS; Krumbein H; Fragkou PC; Hünerbein BL; Reiter R; Papathanasiou KA; Thölken C; Weiss ST; Renz H; Skevaki C
Front Immunol; 2022; 13():1023903. PubMed ID: 36389703
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
[TBL] [Abstract][Full Text] [Related]
10. The role of vitamin D in outcomes of critical care in COVID-19 patients: evidence from an umbrella meta-analysis of interventional and observational studies.
Jamilian A; Ghalichi F; Hamedi Kalajahi F; Radkhah N; Jourabchi N; Musazadeh V; Amini-Salehi E; Zarezadeh M; Ostadrahimi A
Public Health Nutr; 2024 Apr; 27(1):e127. PubMed ID: 38654693
[TBL] [Abstract][Full Text] [Related]
11. High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.
Annweiler C; Beaudenon M; Gautier J; Gonsard J; Boucher S; Chapelet G; Darsonval A; Fougère B; Guérin O; Houvet M; Ménager P; Roubaud-Baudron C; Tchalla A; Souberbielle JC; Riou J; Parot-Schinkel E; Célarier T;
PLoS Med; 2022 May; 19(5):e1003999. PubMed ID: 35639792
[TBL] [Abstract][Full Text] [Related]
12. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: Multicentre randomized controlled clinical trial.
Mariani J; Antonietti L; Tajer C; Ferder L; Inserra F; Sanchez Cunto M; Brosio D; Ross F; Zylberman M; López DE; Luna Hisano C; Maristany Batisda S; Pace G; Salvatore A; Hogrefe JF; Turela M; Gaido A; Rodera B; Banega E; Iglesias ME; Rzepeski M; Gomez Portillo JM; Bertelli M; Vilela A; Heffner L; Annetta VL; Moracho L; Carmona M; Melito G; Martínez MJ; Luna G; Vensentini N; Manucha W
PLoS One; 2022; 17(5):e0267918. PubMed ID: 35622854
[TBL] [Abstract][Full Text] [Related]
15. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial.
Amrein K; Schnedl C; Holl A; Riedl R; Christopher KB; Pachler C; Urbanic Purkart T; Waltensdorfer A; Münch A; Warnkross H; Stojakovic T; Bisping E; Toller W; Smolle KH; Berghold A; Pieber TR; Dobnig H
JAMA; 2014 Oct; 312(15):1520-30. PubMed ID: 25268295
[TBL] [Abstract][Full Text] [Related]
16. The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis.
Bassatne A; Basbous M; Chakhtoura M; El Zein O; Rahme M; El-Hajj Fuleihan G
Metabolism; 2021 Jun; 119():154753. PubMed ID: 33774074
[TBL] [Abstract][Full Text] [Related]
17. Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trial.
Beigmohammadi MT; Bitarafan S; Hoseindokht A; Abdollahi A; Amoozadeh L; Mahmoodi Ali Abadi M; Foroumandi M
Trials; 2020 Jul; 21(1):614. PubMed ID: 32631405
[TBL] [Abstract][Full Text] [Related]
18. The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression.
Tentolouris N; Samakidou G; Eleftheriadou I; Tentolouris A; Jude EB
Diabetes Metab Res Rev; 2022 May; 38(4):e3517. PubMed ID: 34965318
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis.
Pal R; Banerjee M; Bhadada SK; Shetty AJ; Singh B; Vyas A
J Endocrinol Invest; 2022 Jan; 45(1):53-68. PubMed ID: 34165766
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D supplementation for chronic liver diseases in adults.
Bjelakovic G; Nikolova D; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011564. PubMed ID: 29099543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
